Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISSION Nigeria
NCT07707817Recruiting
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in onchocerciasis, schistosomiasis, soil-transmitted helminthiasis (STH) and 1 more. Primary endpoints: Reach percentage at 4 weeks, Coverage percentage at 4 weeks and 10 more. Started Jul 2026; status: recruiting.
02
Conditions
onchocerciasisschistosomiasissoil-transmitted helminthiasis (STH)lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT07707817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707817.